These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30145586)

  • 1. EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts.
    Lavdovskaia ED; Iyevleva AG; Sokolenko AP; Mitiushkina NV; Preobrazhenskaya EV; Tiurin VI; Ivantsov AO; Bizin IV; Stelmakh LV; Moiseyenko FV; Karaseva NA; Orlov SV; Moiseyenko VM; Korzhenevskaya MA; Zaitsev IA; Kozak AR; Chistyakov IV; Akopov AL; Volkov NM; Togo AV; Imyanitov EN
    Oncol Res Treat; 2018; 41(10):634-642. PubMed ID: 30145586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
    Menzel M; Kirchner M; Kluck K; Ball M; Beck S; Allgäuer M; Assmann C; Schnorbach J; Volckmar AL; Tay TKY; Goldschmid H; Tan DS; Thomas M; Kazdal D; Budczies J; Stenzinger A; Christopoulos P
    J Pathol Clin Res; 2024 Mar; 10(2):e354. PubMed ID: 38284983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
    Masuda T; Miura S; Sato Y; Tachihara M; Bessho A; Nakamura A; Miyawaki T; Yoshimine K; Mori M; Shiraishi H; Hamai K; Haratani K; Maeda S; Tabata E; Kitagawa C; Tanizaki J; Imai T; Nogami S; Yamamoto N; Nakagawa K; Hattori N
    Sci Rep; 2023 Nov; 13(1):19729. PubMed ID: 37957228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
    Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
    J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer.
    Lee KWC; Li MSC; Gai W; Lau YM; Chan AKC; Chan OSH; Lee CK; Yeung RMW; Fung SYH; Cheung WF; Chan VW; Leung L; Kam KNP; Mok TSK
    JAMA Oncol; 2023 Feb; 9(2):261-265. PubMed ID: 36580285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer.
    Akkhasutthikun P; Kaewsapsak P; Nimsamer P; Klomkliew P; Visedthorn S; Chanchaem P; Teerapakpinyo C; Payungporn S; Luangdilok S
    Cancer Res Treat; 2024 Apr; 56(2):455-463. PubMed ID: 37986562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.
    Miyazawa H; Tanaka T; Nagai Y; Matsuoka M; ; Sutani A; Udagawa K; Zhang J; Hirama T; Murayama Y; Koyama N; Ikebuchi K; Nagata M; Kanazawa M; Nukiwa T; Takenoshita S; Kobayashi K; Hagiwara K
    Cancer Sci; 2008 Mar; 99(3):595-600. PubMed ID: 18271876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial.
    Chen C; Liu SM; Chen Y; Ou Q; Bao H; Xu L; Zhang Y; Zhang JT; Zhong W; Zhou Q; Yang XN; Shao Y; Wu YL; Liu SY; Li Y
    Cancer Immunol Immunother; 2023 May; 72(5):1261-1272. PubMed ID: 36427086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer.
    Suryavanshi M; Mehta A; Panigrahi MK; Jaipuria J; Saifi M; Jain K; Kumar D; Verma H; Sharma SK; Batra U; Dutta K; Talwar V; Doval DC
    Lung India; 2018; 35(5):384-389. PubMed ID: 30168456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited Tumor Samples.
    Borsu L; Intrieri J; Thampi L; Yu H; Riely G; Nafa K; Chandramohan R; Ladanyi M; Arcila ME
    J Mol Diagn; 2016 Nov; 18(6):903-911. PubMed ID: 27631691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
    Joshi P; Gogte P; Pai T; Gurav M; Dhanawade D; Karnik N; Deshpande G; Kaushal R; Shetty O
    Int J Exp Pathol; 2024 Jun; 105(3):90-99. PubMed ID: 38717047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of
    Shigeto H; Miyata H; Ashizawa T; Iizuka A; Kikuchi Y; Hozumi C; Maeda C; Yamaguchi K; Yamamura S; Akiyama Y
    Cancer Genomics Proteomics; 2023; 20(4):375-382. PubMed ID: 37400147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet Digital PCR as a Molecular Tool for the Detection of the
    Durgut S; Salihefendić L; Pećar D; Čeko I; Mulahuseinović N; Izmirlija M; Konjhodžić R
    Balkan J Med Genet; 2023 Dec; 26(2):21-26. PubMed ID: 38482255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing.
    Xu Z; Li Y; Wang L; Hao X; Ying J; Li J; Xing P
    Expert Rev Anticancer Ther; 2024; 24(3-4):183-192. PubMed ID: 38526910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
    Ihle MA; Heydt C; Schultheis AM; Stöhr R; Haller F; Herold S; Aust D; Dietmaier W; Evert M; Eszlinger M; Haak A; Laßmann S; Vorholt D; Breitenbücher F; Werner M; Streubel A; Mairinger T; Grassow-Narlik M; Merkelbach-Bruse S
    Sci Rep; 2024 Jun; 14(1):13069. PubMed ID: 38844820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ARMS-based assay for the quantification of
    Zhu Y; Guo Z; Liu Y; Zheng X; Yang G; Zheng G
    Oncol Lett; 2018 Mar; 15(3):2905-2912. PubMed ID: 29435017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity.
    Vikis H; Sato M; James M; Wang D; Wang Y; Wang M; Jia D; Liu Y; Bailey-Wilson JE; Amos CI; Pinney SM; Petersen GM; de Andrade M; Yang P; Wiest JS; Fain PR; Schwartz AG; Gazdar A; Gaba C; Rothschild H; Mandal D; Kupert E; Seminara D; Viswanathan A; Govindan R; Minna J; Anderson MW; You M
    Cancer Res; 2007 May; 67(10):4665-70. PubMed ID: 17510392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1.
    Xu Y; Zhao P; Xu X; Zhang S; Xia B; Zhu L
    Biochem Biophys Rep; 2024 Jul; 38():101729. PubMed ID: 38766382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.
    Marchetti A; Del Grammastro M; Filice G; Felicioni L; Rossi G; Graziano P; Sartori G; Leone A; Malatesta S; Iacono M; Guetti L; Viola P; Mucilli F; Cuccurullo F; Buttitta F
    PLoS One; 2012; 7(7):e42164. PubMed ID: 22848739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive and practical method to detect the T790M mutation in the epidermal growth factor receptor.
    Zhao J; Feng HH; Zhao JY; Liu LC; Xie FF; Xu Y; Chen MJ; Zhong W; Li LY; Wang HP; Zhang LI; Xiao YI; Chen WJ; Wang MZ
    Oncol Lett; 2016 Apr; 11(4):2573-2579. PubMed ID: 27073519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.